InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding InMed Pharmaceuticals Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 15 | 10 | −5 |
| Shares | 101.0K | 15.8K | −85.3K (−84.4%) |
| Value | $109.4K | $14.5K | −$94.9K (−86.7%) |
New holders (0)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (5)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Renaissance Technologies LLC | 77,500 | $84.0K |
| UBS Group AG | 2,622 | $2.83K |
| Advisory Services Network, LLC | 6 | $6 |
| TCI Wealth Advisors, Inc. | 5 | $6 |
| Gables Capital Management Inc. | 1 | $1 |